M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study.

M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study. — المؤلف: Ling, Leona E — Clinical pharmacology and therapeutics 20200109

المؤلف
Ling, Leona E
النشر
Clinical pharmacology and therapeutics 20200109
الوصف
1031-1039 p.
الموضوعات
Adult؛ Antibodies؛ Double-Blind Method؛ Female؛ Healthy Volunteers؛ Histocompatibility Antigens Class I؛ Humans؛ Immunoglobulin G